Literature DB >> 12784399

Evaluation of functional disability using the health assessment questionnaire in Japanese patients with systemic sclerosis.

Masataka Kuwana1, Shinichi Sato, Kanako Kikuchi, Yasushi Kawaguchi, Atsushi Fujisaku, Yoshikata Misaki, Atsushi Hatamochi, Hirobumi Kondo, Kazuhiko Takehara.   

Abstract

OBJECTIVE: To assess whether the functional disability in Japanese patients with systemic sclerosis (SSc) can be adequately evaluated by the Health Assessment Questionnaire (HAQ) developed in the United States.
METHODS: The HAQ was completed by 121 Japanese patients with SSc, in whom SSc-specific physical examinations and laboratory tests were performed at the same time. Clinical findings associated with the disability index (DI) and individual components of the HAQ were examined using Student's t tests and Pearson's correlation tests. Logistic regression analysis was used to identify clinical findings that independently contributed to the increase in the HAQ-DI score.
RESULTS: Japanese patients with SSc had significant functional disability, especially in the categories of eating and gripping, but the degree of disability was much less than was reported in previous studies carried out in the US. The increase in the HAQ-DI score was strongly correlated with increased total skin score, reduced oral aperture, reduced hand extension, increased finger flexion, subcutaneous calcinosis, flexion contractures, increased erythrocyte sedimentation rates, decreased percent vital capacity, and vascular involvement (p < 0.001 for all correlations). Multivariate logistic regression analysis showed that hand extension was the most important and an independent correlate of the HAQ-DI.
CONCLUSION: Our multicenter, cross-sectional study has demonstrated that the self-administered HAQ is a valuable assessment tool of functional disability in Japanese SSc patients, who have social customs different from Americans, but functional disability measured by the HAQ is potentially influenced by ethnic variability.

Entities:  

Mesh:

Year:  2003        PMID: 12784399

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  5 in total

1.  Cross-cultural adaptation and validation of the Brazilian version of the Scleroderma Health Assessment Questionnaire (SHAQ).

Authors:  Luiza F Rocha; Roberta G Marangoni; Percival D Sampaio-Barros; Mauricio Levy-Neto; Natalino H Yoshinari; Eloisa Bonfa; Virginia Steen; Sergio C Kowalski
Journal:  Clin Rheumatol       Date:  2013-08-22       Impact factor: 2.980

Review 2.  Clinical significance and usefulness of rehabilitation for systemic sclerosis.

Authors:  Naoki Mugii; Yasuhito Hamaguchi; Susanna Maddali-Bongi
Journal:  J Scleroderma Relat Disord       Date:  2018-04-04

3.  Efficacy of connective tissue massage and Mc Mennell joint manipulation in the rehabilitative treatment of the hands in systemic sclerosis.

Authors:  Susanna Maddali Bongi; Angela Del Rosso; Felice Galluccio; Fabrizio Sigismondi; Irene Miniati; M Letizia Conforti; Francesca Nacci; Marco Matucci Cerinic
Journal:  Clin Rheumatol       Date:  2009-06-25       Impact factor: 2.980

4.  Antifibrotic effects of 2-carba cyclic phosphatidic acid (2ccPA) in systemic sclerosis: contribution to the novel treatment.

Authors:  Tomoaki Higuchi; Kae Takagi; Akiko Tochimoto; Yuki Ichimura; Takanari Norose; Yasuhiro Katsumata; Ikuko Masuda; Hisashi Yamanaka; Toshiro Morohoshi; Yasushi Kawaguchi
Journal:  Arthritis Res Ther       Date:  2019-04-18       Impact factor: 5.156

5.  Serum adhesion molecule levels as prognostic markers in patients with early systemic sclerosis: a multicentre, prospective, observational study.

Authors:  Minoru Hasegawa; Yoshihide Asano; Hirahito Endo; Manabu Fujimoto; Daisuke Goto; Hironobu Ihn; Katsumi Inoue; Osamu Ishikawa; Yasushi Kawaguchi; Masataka Kuwana; Fumihide Ogawa; Hiroki Takahashi; Sumiaki Tanaka; Shinichi Sato; Kazuhiko Takehara
Journal:  PLoS One       Date:  2014-02-06       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.